STOCK TITAN

Cancer diagnosis? Sun Life's Expert Cancer Review provides a lifeline to second opinions

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Negative)
Tags
Sun Life U.S. (SLF) has launched Expert Cancer Review, a new service embedded in their stop-loss insurance plans starting July 1, 2025. The service provides cancer patients access to independent oncology specialist second opinions. This initiative addresses a critical healthcare need, as cancer represents the highest-cost claims, accounting for over 40% of total claims spend, particularly among adults aged 40-59. Data from 2023-2024 shows that 39% of members seeking second opinions experienced changes in their diagnostic strategy, diagnosis, or treatment plan. The service leverages Health Navigator's expertise, offering dedicated care advisors who coordinate with independent oncologists to provide comprehensive reviews in plain language to both members and treating physicians. This service will be available to self-funded employee health plans, which cover 63% of U.S. workers according to KFF.
Sun Life U.S. (SLF) ha lanciato Expert Cancer Review, un nuovo servizio integrato nei loro piani di assicurazione stop-loss a partire dal 1° luglio 2025. Il servizio offre ai pazienti oncologici l'accesso a second opinion indipendenti da specialisti in oncologia. Questa iniziativa risponde a un'esigenza cruciale nel settore sanitario, poiché il cancro rappresenta la voce di spesa più elevata, coprendo oltre il 40% delle richieste totali, specialmente tra gli adulti tra i 40 e i 59 anni. I dati del 2023-2024 mostrano che il 39% dei membri che hanno richiesto una seconda opinione ha visto modifiche nella strategia diagnostica, nella diagnosi o nel piano di trattamento. Il servizio si avvale dell'esperienza di Health Navigator, offrendo consulenti dedicati che coordinano con oncologi indipendenti per fornire revisioni complete in un linguaggio chiaro sia ai membri che ai medici curanti. Questo servizio sarà disponibile per i piani sanitari autofinanziati per i dipendenti, che coprono il 63% dei lavoratori statunitensi secondo KFF.
Sun Life U.S. (SLF) ha lanzado Expert Cancer Review, un nuevo servicio incorporado en sus planes de seguro stop-loss a partir del 1 de julio de 2025. El servicio brinda a los pacientes con cáncer acceso a segundas opiniones independientes de especialistas en oncología. Esta iniciativa responde a una necesidad crítica en el cuidado de la salud, ya que el cáncer representa los reclamos de mayor costo, representando más del 40% del gasto total en reclamos, especialmente entre adultos de 40 a 59 años. Los datos de 2023-2024 muestran que el 39% de los miembros que buscaron segundas opiniones experimentaron cambios en su estrategia diagnóstica, diagnóstico o plan de tratamiento. El servicio aprovecha la experiencia de Health Navigator, ofreciendo asesores dedicados que coordinan con oncólogos independientes para proporcionar revisiones completas en lenguaje sencillo tanto a los miembros como a los médicos tratantes. Este servicio estará disponible para planes de salud autofinanciados para empleados, que cubren al 63% de los trabajadores en EE.UU. según KFF.
Sun Life U.S. (SLF)는 2025년 7월 1일부터 스톱로스 보험 플랜에 통합된 새로운 서비스인 Expert Cancer Review를 출시했습니다. 이 서비스는 암 환자에게 독립적인 종양학 전문의의 2차 소견을 제공하는 것을 목표로 합니다. 암은 전체 청구 비용의 40% 이상을 차지하는 가장 높은 비용 청구 항목으로, 특히 40~59세 성인에서 두드러지며, 이 서비스는 중요한 의료 수요를 해결합니다. 2023-2024년 데이터에 따르면 2차 소견을 구한 회원의 39%가 진단 전략, 진단 또는 치료 계획에 변화가 있었습니다. 이 서비스는 Health Navigator의 전문성을 활용하여 전담 케어 어드바이저가 독립 종양학자와 협력해 회원과 치료 의사 모두에게 이해하기 쉬운 종합 검토를 제공합니다. 이 서비스는 KFF에 따르면 미국 근로자의 63%를 커버하는 자가 자금 조달 직원 건강 보험 플랜에서 이용할 수 있습니다.
Sun Life U.S. (SLF) a lancé Expert Cancer Review, un nouveau service intégré à leurs plans d'assurance stop-loss à partir du 1er juillet 2025. Ce service offre aux patients atteints de cancer un accès à des secondes opinions indépendantes d'oncologues spécialistes. Cette initiative répond à un besoin crucial en santé, car le cancer représente les réclamations les plus coûteuses, représentant plus de 40 % du total des dépenses de réclamations, notamment chez les adultes de 40 à 59 ans. Les données de 2023-2024 montrent que 39 % des membres ayant sollicité une seconde opinion ont vu leur stratégie diagnostique, diagnostic ou plan de traitement modifiés. Le service s'appuie sur l'expertise de Health Navigator, offrant des conseillers dédiés qui coordonnent avec des oncologues indépendants pour fournir des revues complètes en langage clair aux membres comme aux médecins traitants. Ce service sera disponible pour les régimes de santé autofinancés des employés, qui couvrent 63 % des travailleurs américains selon KFF.
Sun Life U.S. (SLF) hat Expert Cancer Review eingeführt, einen neuen Service, der ab dem 1. Juli 2025 in ihre Stop-Loss-Versicherungspläne integriert wird. Der Service bietet Krebspatienten Zugang zu unabhängigen Zweitmeinungen von Onkologie-Spezialisten. Diese Initiative adressiert einen kritischen Gesundheitsbedarf, da Krebs die kostenintensivsten Ansprüche darstellt und über 40 % der Gesamtausgaben für Ansprüche ausmacht, insbesondere bei Erwachsenen im Alter von 40 bis 59 Jahren. Daten aus den Jahren 2023-2024 zeigen, dass 39 % der Mitglieder, die eine Zweitmeinung einholten, Änderungen in ihrer diagnostischen Strategie, Diagnose oder Behandlungsplanung erfuhren. Der Service nutzt die Expertise von Health Navigator und stellt dedizierte Pflegeberater bereit, die mit unabhängigen Onkologen zusammenarbeiten, um umfassende Überprüfungen in verständlicher Sprache sowohl für Mitglieder als auch behandelnde Ärzte bereitzustellen. Dieser Service wird für selbstfinanzierte Mitarbeiterversicherungspläne verfügbar sein, die laut KFF 63 % der US-Arbeitnehmer abdecken.
Positive
  • Service is automatically embedded in new and renewing stop-loss plans at no additional cost
  • Addresses the highest-cost claims category (cancer) which accounts for 40% of total claims spend
  • 39% of second opinions led to changes in diagnostic strategy or treatment plans
  • Leverages existing Health Navigator infrastructure for seamless implementation
Negative
  • None.

Insights

Sun Life embeds expert cancer second opinion service into stop-loss plans, potentially improving outcomes while addressing their largest claims category.

Sun Life's new Expert Cancer Review service represents a strategic enhancement to their stop-loss insurance portfolio. By providing access to second opinions from independent oncology specialists, Sun Life is directly addressing what their data identifies as their most significant claims expense - cancer diagnoses account for more than 40% of their total claims spend.

The business case is compelling: Sun Life's internal data shows that 39% of members who sought second opinions experienced changes in their diagnostic strategy, diagnosis, or treatment plan. By embedding this service in all new and renewing stop-loss plans beginning July 1, Sun Life creates potential value on multiple fronts:

  • For self-funded employers: Enhanced benefits without additional explicit costs
  • For members: Improved diagnostic confidence and potentially more appropriate treatment
  • For Sun Life: Possible reduction in unnecessary or ineffective treatments that drive high-cost claims

This move aligns with the industry trend toward insurers evolving from pure financial risk-bearers to healthcare solution providers. By leveraging their existing Health Navigator platform, Sun Life can deliver this specialized service efficiently while positioning themselves as a more comprehensive partner to the 63% of U.S. workers covered by self-funded health plans.

The integration of clinical expertise with their core insurance offering demonstrates Sun Life's understanding that better healthcare navigation can create value for all stakeholders in the self-funded ecosystem. This enhancement strengthens their market position in the competitive stop-loss insurance landscape while addressing a critical healthcare need.

New service embedded in Sun Life stop-loss coverage boosts employees' understanding of cancer diagnoses and confidence in treatment plans

WELLESLEY, Mass., June 18, 2025 /PRNewswire/ -- Sun Life U.S., the leading independent provider of medical stop-loss insurance in the country, today announced the launch of its Expert Cancer Review service, which provides members facing a cancer diagnosis with access to an objective, documented second opinion from an independent oncology specialist. The new service will be embedded in new and renewing Sun Life stop-loss plans beginning July 1.

The introduction of Expert Cancer Review comes at a crucial time in healthcare. Sun Life's annual high-cost claims report shows that cancer consistently ranks as the most common and costly condition across the country. Malignant neoplasm diagnoses, particularly in adults ages 40-59, account for more than 40% of total claims spend. Ensuring the best treatment plan is in place can provide peace of mind and prevent delays in treatment or unnecessary medical costs for the member undergoing care.  

"As a former nurse, I recognize the profound impact a cancer diagnosis can have on people. By offering access to expert second opinions, we will be able to empower our members with knowledge and give them confidence in their cancer treatment plans," said Jennifer Collier, president, Health and Risk Solutions, Sun Life U.S. "This new service reflects our commitment to helping members get the care they need, ensuring they are supported and well informed during a challenging time."

Second opinions, whether for cancer or other diagnoses, can have significant impact on the patient's health journey. Sun Life data from 2023-2024 showed that 39% of members who sought second opinions from qualified specialists saw a change in their diagnostic strategy, diagnosis or treatment plan.

Collier continued, "Second opinions can be a game changer, potentially avoiding misdiagnoses, sparing people from unnecessary treatments, uncovering better-tailored therapies and even reducing medical costs."

Expert Cancer Review harnesses the clinical expertise of Health Navigator, Sun Life's healthcare navigation and advocacy service. Health Navigator provides support for all health conditions with one-on-one care advisors who help members get the right diagnoses, doctors and treatments. For members using Expert Cancer Review, this dedicated team coordinates with independent expert oncologists to ensure thorough reviews and answer questions. The resulting opinions, written in plain language, are sent to the member and treating physician. 

As a stop-loss provider, Sun Life covers high-dollar claims for employers who self-fund their employee health plans. According to KFF, an independent non-profit organization focused on national health issues, 63% of covered workers in the U.S. are in a plan that is self-funded.

About Sun Life

Sun Life is a leading international financial services organization providing asset management, wealth, insurance and health solutions to individual and institutional Clients. Sun Life has operations in a number of markets worldwide, including Canada, the United States, the United Kingdom, Ireland, Hong Kong, the Philippines, Japan, Indonesia, India, China, Australia, Singapore, Vietnam, Malaysia and Bermuda. As of March 31, 2025, Sun Life had total assets under management of C$1.55 trillion. For more information, please visit www.sunlife.com.

Sun Life Financial Inc. trades on the Toronto (TSX), New York (NYSE) and Philippine (PSE) stock exchanges under the ticker symbol SLF.

Sun Life U.S. is one of the largest providers of employee and government benefits, helping approximately 50 million Americans access the care and coverage they need. Through employers, industry partners and government programs, Sun Life U.S. offers a portfolio of benefits and services, including dental, vision, disability, absence management, life, supplemental health, medical stop-loss insurance, and healthcare navigation. Sun Life employs more than 8,300 people in the U.S., including associates in our partner dental practices and affiliated companies in asset management. Group insurance policies are issued by Sun Life Assurance Company of Canada (Wellesley Hills, Mass.), except in New York, where policies are issued by Sun Life and Health Insurance Company (U.S.) (Lansing, Mich.). For more information visit our website and newsroom.

Anjie Coplin
Sun Life U.S.
Anjie.Coplin@sunlife.com

Connect with Sun Life U.S.

https://www.facebook.com/SLFUnitedStates   
https://www.linkedin.com/company/sun-life-financial  

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cancer-diagnosis-sun-lifes-expert-cancer-review-provides-a-lifeline-to-second-opinions-302484565.html

SOURCE Sun Life U.S.

FAQ

What is Sun Life's Expert Cancer Review service and when does it launch?

Expert Cancer Review is a service providing cancer patients access to independent oncology specialist second opinions, launching July 1, 2025 for Sun Life stop-loss insurance plans.

How effective are second opinions according to Sun Life's (SLF) data?

According to Sun Life's 2023-2024 data, 39% of members who sought second opinions experienced changes in their diagnostic strategy, diagnosis, or treatment plan.

What percentage of claims spend does cancer represent in Sun Life's stop-loss coverage?

Cancer (malignant neoplasm) diagnoses account for more than 40% of total claims spend, particularly in adults ages 40-59.

How does Sun Life's Expert Cancer Review service work?

The service uses Health Navigator's care advisors who coordinate with independent oncologists to review cases and provide written opinions in plain language to both the member and treating physician.

Who is eligible for Sun Life's Expert Cancer Review service?

The service is available to members covered under Sun Life stop-loss plans, which typically include employees in self-funded health plans (representing 63% of covered U.S. workers).
Sun Life Finl

NYSE:SLF

SLF Rankings

SLF Latest News

SLF Stock Data

35.54B
562.90M
0.04%
55.8%
2.87%
Insurance - Diversified
Financial Services
Link
Canada
Toronto